Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 6/13 December 2014, Vol 293, No 7839/40

Sort by: Newest first Oldest first A-Z Z-A

  • Disillusioned with the future of pharmacy Subscription

    20 NOV 2014 9:59 By Anna Durbin

    After becoming qualified and working as a locum community pharmacist for over a year, I am already disillusioned by what the future of pharmacy will be. I agree with Adnan Baig’s letter (The Pharmaceutical Journal 2014:293:524) regarding how an uncontrolled, competitive market will undermine the profession. Throughout my studies I have worked hard with the hope of becoming ...

  • The World Health Organization (WHO) puts pressure on drug manufacturers to make clinical trial data publicly accessible

    WHO joins drive to make all clinical trial data publicly available Subscription

    19 NOV 2014 17:03 By Debbie Andalo
    Comments (1)

    The World Health Organization has issued an official statement to encourage pharmaceutical companies to publicly disclose clinical trial results.

  • Recivit sublingual tablets recall Subscription

    19 NOV 2014 14:37

    The Medicines and Healthcare products Regulatory Agency has issued a company-led recall for specific batches of Recivit (fentanyl citrate; Grünenthal) sublingual tablets. This is because there is a possibility that certain batches will have blisters that have tablets missing or contain two tablets in a single blister cavity.

  • Winter pressures funding Subscription

    19 NOV 2014 14:27

    14 November 2014: The government announced that a further £300m is being invested to help the NHS in England deal with winter pressures this year. As part of the announcement, patients are being encouraged to make more use of pharmacists and seek early advice from them. The Royal Pharmaceutical Society (RPS) featured on a number of news outlets speaking about this story, including Good Morning Britain, Sky News and LBC.

  • Beware the power of knowing your customer

    19 NOV 2014 By Emma Page

    The new profiling tool on the YouGov website is entertaining but has the potential to mislead, writes Emma Page

  • The role of chief scientific adviser to the European Commission, formerly held by Anne Glover, has been scrapped

    Role of chief scientific adviser at European Commission scrapped Subscription

    18 NOV 2014 17:22 By Debbie Andalo

    Move to scrap the role of chief scientific adviser has been described as ‘deeply disappointing’.

  • The cost of medicines prescribed by hospitals in England increased by 15.1% to £5.8bn, data from the Health and Social Care Information Centre show

    NHS expenditure on prescribed medicines up by 7.6%, with 15.1% increase in hospital sector Subscription

    18 NOV 2014 17:22 By Tamsin Newton Snow

    The cost of medicines prescribed by hospitals in England increased by 15.1% to £5.8bn in 2013–2014 compared with the previous year.

  • Pevaryl cream is not recommended during pregnancy Subscription

    18 NOV 2014 10:08

    Pevaryl (econazole nitrate; Janssen-Cilag) topical cream 1% is not recommended during pregnancy, because there is low systemic absorption of econazole, according to the updated summary of product characteristics. 

  • Medicines compliance aid database Subscription

    18 NOV 2014 10:06

    UK Medicines Information (UKMi) has developed a medicines compliance aid database that makes recommendations on the suitability of solid dose forms for transfer from the manufacturers’ original packaging to multi-compartment compliance aids. The database should be used alongside the Royal Pharmaceutical Society guidance about ‘Improving ...

  • Lescol capsules discontinued Subscription

    18 NOV 2014 10:05

    Novartis has discontinued Lescol (fluvastatin) capsules 40mg x 56. No other pack sizes are affected at this time. Medical information on 01276 698370.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.